Publication Information

{'id': 'https://openalex.org/W1965803528', 'doi': 'https://doi.org/10.1212/wnl.35.8.1196', 'title': "Combined bromocriptine-levodopa therapy early in Parkinson's disease", 'display_name': "Combined bromocriptine-levodopa therapy early in Parkinson's disease", 'publication_year': 1985, 'publication_date': '1985-08-01', 'ids': {'openalex': 'https://openalex.org/W1965803528', 'doi': 'https://doi.org/10.1212/wnl.35.8.1196', 'mag': '1965803528', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/4022354'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1212/wnl.35.8.1196', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S79704628', 'display_name': 'Neurology', 'issn_l': '0028-3878', 'issn': ['0028-3878', '1526-632X'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5111959126', 'display_name': 'Urpo K. Rinne', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I155660961', 'display_name': 'University of Turku', 'ror': 'https://ror.org/05vghhr25', 'country_code': 'FI', 'type': 'education', 'lineage': ['https://openalex.org/I155660961']}], 'countries': ['FI'], 'is_corresponding': True, 'raw_author_name': 'Urpo K. Rinne', 'raw_affiliation_strings': ['Department of Neurology, University of Turku, Turku, Finland.'], 'affiliations': [{'raw_affiliation_string': 'Department of Neurology, University of Turku, Turku, Finland.', 'institution_ids': ['https://openalex.org/I155660961']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5111959126'], 'corresponding_institution_ids': ['https://openalex.org/I155660961'], 'apc_list': None, 'apc_paid': None, 'fwci': 6.928, 'has_fulltext': False, 'cited_by_count': 115, 'citation_normalized_percentile': {'value': 0.930556, 'is_in_top_1_percent': False, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 97, 'max': 98}, 'biblio': {'volume': '35', 'issue': '8', 'first_page': '1196', 'last_page': '1196'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10085', 'display_name': "Parkinson's Disease Mechanisms and Treatments", 'score': 0.9835, 'subfield': {'id': 'https://openalex.org/subfields/2728', 'display_name': 'Neurology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10085', 'display_name': "Parkinson's Disease Mechanisms and Treatments", 'score': 0.9835, 'subfield': {'id': 'https://openalex.org/subfields/2728', 'display_name': 'Neurology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11611', 'display_name': 'Cyclopropane Reaction Mechanisms', 'score': 0.9814, 'subfield': {'id': 'https://openalex.org/subfields/1605', 'display_name': 'Organic Chemistry'}, 'field': {'id': 'https://openalex.org/fields/16', 'display_name': 'Chemistry'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}, {'id': 'https://openalex.org/T11549', 'display_name': 'Synthetic Organic Chemistry Methods', 'score': 0.9614, 'subfield': {'id': 'https://openalex.org/subfields/1605', 'display_name': 'Organic Chemistry'}, 'field': {'id': 'https://openalex.org/fields/16', 'display_name': 'Chemistry'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C2776856834', 'wikidata': 'https://www.wikidata.org/wiki/Q413581', 'display_name': 'Bromocriptine', 'level': 4, 'score': 0.98680174}, {'id': 'https://openalex.org/C2780304432', 'wikidata': 'https://www.wikidata.org/wiki/Q300989', 'display_name': 'Levodopa', 'level': 4, 'score': 0.9406785}, {'id': 'https://openalex.org/C2780405171', 'wikidata': 'https://www.wikidata.org/wiki/Q629444', 'display_name': 'Dyskinesia', 'level': 4, 'score': 0.74469256}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.6857972}, {'id': 'https://openalex.org/C2776525014', 'wikidata': 'https://www.wikidata.org/wiki/Q1531991', 'display_name': 'Parkinsonism', 'level': 3, 'score': 0.66399074}, {'id': 'https://openalex.org/C2778258207', 'wikidata': 'https://www.wikidata.org/wiki/Q600203', 'display_name': 'Dopamine agonist', 'level': 4, 'score': 0.5639545}, {'id': 'https://openalex.org/C2779734285', 'wikidata': 'https://www.wikidata.org/wiki/Q11085', 'display_name': "Parkinson's disease", 'level': 3, 'score': 0.5003567}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.3632372}, {'id': 'https://openalex.org/C42219234', 'wikidata': 'https://www.wikidata.org/wiki/Q131130', 'display_name': 'Anesthesia', 'level': 1, 'score': 0.3302672}, {'id': 'https://openalex.org/C513476851', 'wikidata': 'https://www.wikidata.org/wiki/Q170304', 'display_name': 'Dopamine', 'level': 2, 'score': 0.32017893}, {'id': 'https://openalex.org/C2779134260', 'wikidata': 'https://www.wikidata.org/wiki/Q12136', 'display_name': 'Disease', 'level': 2, 'score': 0.29789782}, {'id': 'https://openalex.org/C137183658', 'wikidata': 'https://www.wikidata.org/wiki/Q461076', 'display_name': 'Dopaminergic', 'level': 3, 'score': 0.201321}, {'id': 'https://openalex.org/C2779064019', 'wikidata': 'https://www.wikidata.org/wiki/Q66590068', 'display_name': 'Prolactin', 'level': 3, 'score': 0.12855497}, {'id': 'https://openalex.org/C71315377', 'wikidata': 'https://www.wikidata.org/wiki/Q11364', 'display_name': 'Hormone', 'level': 2, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D001971', 'descriptor_name': 'Bromocriptine', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D007980', 'descriptor_name': 'Levodopa', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D010300', 'descriptor_name': 'Parkinson Disease', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D001971', 'descriptor_name': 'Bromocriptine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004185', 'descriptor_name': 'Disability Evaluation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004305', 'descriptor_name': 'Dose-Response Relationship, Drug', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004338', 'descriptor_name': 'Drug Combinations', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007980', 'descriptor_name': 'Levodopa', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010300', 'descriptor_name': 'Parkinson Disease', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010300', 'descriptor_name': 'Parkinson Disease', 'qualifier_ui': 'Q000503', 'qualifier_name': 'physiopathology', 'is_major_topic': False}, {'descriptor_ui': 'D013997', 'descriptor_name': 'Time Factors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1212/wnl.35.8.1196', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S79704628', 'display_name': 'Neurology', 'issn_l': '0028-3878', 'issn': ['0028-3878', '1526-632X'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/4022354', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being', 'score': 0.77}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4290398965', 'https://openalex.org/W2465771749', 'https://openalex.org/W2416992253', 'https://openalex.org/W2315774369', 'https://openalex.org/W2124414252', 'https://openalex.org/W2042115553', 'https://openalex.org/W2024397203', 'https://openalex.org/W1991088298', 'https://openalex.org/W1985841738', 'https://openalex.org/W1965803528'], 'abstract_inverted_index': {'Compared': [0], 'with': [1, 9, 56, 65], 'levodopa,': [2], 'treatment': [3], 'of': [4, 29, 53, 69], 'parkinsonism': [5], 'for': [6], '3': [7], 'years': [8], 'bromocriptine': [10, 38, 42], 'alone': [11], 'resulted': [12], 'in': [13, 23], 'less': [14, 21], 'fluctuation': [15], 'and': [16, 43, 59, 71], 'peak-dose': [17, 60], 'dyskinesia,': [18], 'but': [19], 'also': [20], 'improvement': [22], 'parkinsonian': [24], 'disability.': [25], 'Only': [26], 'a': [27, 47, 66, 72], 'few': [28], 'the': [30], '76': [31], 'patients': [32], 'had': [33, 46], 'long-term': [34], 'benefit': [35], 'on': [36], 'chronic': [37], 'therapy.': [39], 'However,': [40], 'combined': [41], 'levodopa': [44, 54, 70], 'therapy': [45], 'therapeutic': [48], 'response': [49], 'equal': [50], 'to': [51], 'that': [52], 'alone,': [55], 'fewer': [57], 'fluctuations': [58], 'dyskinesias.': [61], 'Treatment': [62], 'should': [63], 'begin': [64], 'low': [67], 'dose': [68], 'dopamine': [73], 'agonist.': [74]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1965803528', 'counts_by_year': [{'year': 2022, 'cited_by_count': 1}, {'year': 2021, 'cited_by_count': 1}, {'year': 2020, 'cited_by_count': 1}, {'year': 2017, 'cited_by_count': 1}, {'year': 2016, 'cited_by_count': 1}, {'year': 2013, 'cited_by_count': 1}], 'updated_date': '2024-12-10T00:33:30.053895', 'created_date': '2016-06-24'}